References

Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention

10.1016/s2213-8587(19)30081-6 · 2019 · External reference

Diabetic neuropathy

10.1038/s41572-019-0092-1 · 2019 · External reference

Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments

10.1016/s1474-4422(22)00188-0 · 2022 · External reference

The global and regional burden of diabetic peripheral neuropathy

10.1038/s41582-024-01041-y · 2025 · External reference

Peripheral neuropathy: a review

10.1001/jama.2025.19400 · 2026 · External reference

Increased systemic immune-inflammation index was associated with type 2 diabetic peripheral neuropathy: a cross-sectional study in the chinese population

10.2147/jir.s433843 · 2023 · External reference

Diabetic neuropathy: cutting-edge research and future directions

10.1038/s41392-025-02175-1 · 2025 · External reference

Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: an extensive literature review

10.4103/tjem.tjem_198_23 · 2024 · External reference

Association of systemic immune inflammatory index with all-cause and cause-specific mortality in hypertensive individuals: results from NHANES

10.3389/fimmu.2023.1087345 · 2023 · External reference

Association of the systemic immune-inflammation index (SII) and clinical outcomes in patients with stroke: a systematic review and meta-analysis

10.3389/fimmu.2022.1090305 · 2022 · External reference

Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications

10.3389/fendo.2024.1367376 · 2024 · External reference

Inflammatory markers used as predictors of subclinical atherosclerosis in patients with diabetic polyneuropathy

10.3390/life13091861 · 2023 · External reference

Five stages of evolving beta-cell dysfunction during progression to diabetes

10.2337/diabetes.53.suppl_3.s16 · 2004 · External reference

Type 2 diabetes and its impact on the immune system

10.2174/1573399815666191024085838 · 2020 · External reference

Platelets selectively regulate the release of BDNF, but not that of its precursor protein, proBDNF

10.3389/fimmu.2020.575607 · 2020 · External reference

The link between BDNF and platelets in neurological disorders

10.1016/j.heliyon.2024.e39278 · 2024 · External reference

c-jun reprograms schwann cells of injured nerves to generate a repair cell essential for regeneration

10.1016/j.neuron.2012.06.021 · 2012 · External reference

Research progress on the role of PDGF/PDGFR in type 2 diabetes

10.1016/j.biopha.2023.114983 · 2023 · External reference

Human platelets contain brain-derived neurotrophic factor

10.1523/jneurosci.10-11-03469.1990 · 1990 · External reference

Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the src-family kinase activation

10.1186/s12933-017-0505-y · 2017 · External reference